Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Medtronic received the go-ahead to begin an at-home U.S. trial of its Low Glucose Suspend technology that aims to prevent hypoglycemia by automatically stopping basal insulin delivery when measured glucose reaches a critically low level.
The pump technology is already available in Europe on the company?s Paradigm Veo insulin pump
http://medgadget.com/2011/11/medtro...ser-to-artificial-pancreas-functionality.html
The pump technology is already available in Europe on the company?s Paradigm Veo insulin pump
http://medgadget.com/2011/11/medtro...ser-to-artificial-pancreas-functionality.html